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Abstract—Among all cardiovascular diseases, congestive heart
failure (CHF) has a very high rate of hospitalization and
mortality. In order to prevent hospitalization, there is a strong
need to identify patients at risk of a CHF event by estimating a set
of relevant hemodynamic parameters that will allow physicians to
detect its early onset. Today, one of the most popular non-invasive
methods to obtain these parameters is through the acquisition of
electrocardiogram (ECG) and impedance cardiogram (ICG) by
using large hospital systems with electrodes placed on the chest
and thorax region. In order to be useful in an ambulatory setting,
it is important to obtain an ultra-low power wearable system for
acquiring the ICG and ECG, and to detect CHF. In this paper,
we present a touch-based ultra-low power device for real-time
ICG and ECG signal acquisition, and hemodynamic parameters
estimation. We also propose methods for noise cancellation and
for calculating the hemodynamic parameters. In addition, a
comparative evaluation of susceptibility to different measuring
positions is presented. Our proposed design is highly correlated
with traditional systems (> 80%), but able to work with very
low power budgets, thus allowing long duration of operation of
over four days on a single battery charge.
I. INTRODUCTION
Congestive heart failure (CHF) is one of the major pub-
lic health issues, and is characterized by frequent hospital
admissions and high mortality rates. It has been estimated
that annually in the United States alone, nearly 5 million
patients are affected by CHF [1]. CHF is a condition in which
the heart fails to pump enough blood to meet the body’s
needs impeding the proper cells’ nourishment. It is usually
preceded by an increase of fluid in the thoracic cavity. In
addition, it is accompanied by swelling of limbs, shortness
of breath, quick weight gain as well as irregular heartbeat.
Many studies have been conducted in an attempt to detect early
onset of CHF. For instance, in [2], the authors indicate that,
on average, weight gain is an important risk factor preceding
the hospitalisation within a relatively short period, but their
results do not indicate that all hospitalizations are preceded by
weight gain. Furthermore, in order to prevent hospitalization,
there is a need to identify patients at risk of a major heart
failure event by estimating some more relevant and more
reliable parameters. Hemodynamic parameters can be used as
relevant parameters for detecting an early onset of CHF, a
particularly important time when CHF can still be prevented
by change of medication [3]. These parameters are used to
determine how efficiently the heart pumps blood through the
Fig. 1: Traditional electrode configuration setup. [5]
cardiovascular system. Determining them is of the utmost
importance as the proper blood circulation is a necessary
condition for adequate supply of oxygen to all tissues. Gold
standard techniques used for these purposes are invasive, and
involve many risks [4]. For these reasons, in the last two
decades several non-invasive methods have been proposed to
monitor cardiac hemodynamics.
We focus on Impedance cardiogram (ICG), which is a
key technique for non-invasive methods in assessing these
hemodynamic parameters as well as the fluid level status. ICG
measurement process is usually conducted by four electrodes,
(Fig. 1). In this process, an alternating current (AC) of low
amplitude is injected across the human body through the outer
electrodes, and the voltage is measured through the inner
ones. ICG has usually been recorded by large systems, by
means of cables connected to electrodes, which are placed
on the chest, permitting the current injection. Thus, today’s
ICG acquisition methods are not conducive for point-of-care
use by patients, wherein the hemodynamic parameters can be
measured quickly and conveniently.
In this paper, we present a touch-based ultra-low power
device, easy to use as shown in Fig. 2, which allows real-
time ICG and ECG signals acquisition by touch. The main
contributions of this paper are the following:
1) A point-of-care device for beat-to-beat ECG and ICG
signal acquisition from fingers, which includes algo-
rithms and methods for embedded real-time ECG and
ICG filtering.
2) Showing the correlation between signals obtained from
our touch-based low-power device and those obtained
through the traditional method for ICG signal acquisition
which involves the placement of the electrodes on the
human’s body.
Fig. 2: Touch-based ultra-low power device
3) Quantifying the error which occurs due to device dis-
placement during measurements.
4) Methods to obtain relevant hemodynamic parameters.
This paper is organized as follows. Previous work on ICG
is described in Section 2. The design methodology used in
this study is presented in Section 3. Finally, experiments
and results are shown in Section 4, whilst conclusions are
discussed in Section 5.
II. RELATED WORK
Several studies have been recently conducted in an attempt
to investigate the usefulness of ICG as a reliable and non-
invasive technique for body composition assessment as well
as for disease prediction. In [6], the authors showed that ICG
could be used as an accurate and reproducible alternative to
invasive techniques for measuring hemodynamic parameters in
patients with ischemic cardiomyopathy, either at rest or during
upright exercise. Furthermore, in [7] it has been shown that
ICG can identify patients at highest and lowest short-term risk
for a heart failure event. One of the methods for peripheral
and pulmonary edema detection was described in [8]. A study
which uses ICG in order to obtain valid and reliable estimates
of cardiac function in persons with hypertension is described
[9]. Thoracic fluid content measured by ICG has been used
as a parameter for predicting beneficial effects of cardiac
rehabilitation in patients suffering from CHF in [10]. ICG
has also been studied in the evaluation of the hemodynamic
responses during psychological stress in [11].
Some of the commercial devices for ICG signal acquisition
are Philips ICG monitor [12] and LIFEGARD II Multi-
Parameter Patient Monitor [13]. A measuring board based
on low-power ECG and ICG is proposed in [14]. In order
to acquire signals, these devices use electrodes placed on the
neck and on the thorax, whereas our proposed system operates
simply by fingers’ touch.
ICG signal is usually contaminated by two main artifacts:
respiratory and motion artifacts. ICG signal spans the fre-
quency range (0.8− 20)Hz, while respiratory and motion
artifacts have frequency components in (0.04− 2)Hz and
(0.1− 10)Hz, respectively [15]. Different techniques for ICG
artifacts suppression have been reported in the literature [16],
[17].
III. HARDWARE DESIGN METHODOLOGY
The system used in this experiment is shown in Fig. 2.
This device features a sensor which enables obtaining both
ECG and ICG signals at the same time in a continuous
Fig. 3: Proposed algorithm flowchart for ICG and ECG signal
acquisition
Fig. 4: Block diagram of the reference node architecture
manner, just by touch. The frequency of the injected current
for ICG measurements, as well as the sampling frequency of
the physiological signals are adjustable.
A. Hardware architecture
• The ECG and ICG sensor describes the hardware com-
ponent that acquires and samples the raw signal. Then,
the samples are quantized by an A/D converter using a
number of bits that depends on its resolution. Sampling
frequency goes from 125Hz up to 16Khz with up
to 16bits resolution. We use a standard ECG front-
end (ADS1291) [18] and a proprietary sensor for ICG
acquisition.
• The STM32L151 [19] is an ultra-low power 32-bit mi-
crocontroller which can operate at a maximum frequency
of 32 MHz, has 48 KB RAM, 384 KB Flash and analog
peripherals including a 12-bit ADC.
• The accelerometer and gyroscope sense motion, which
are used for to distinguish different positions.
• The radio describes the hardware used to transmit the
data though the wireless channel. We use Bluetooth low
energy (nRF8001) [20].
• The Power Management Unit (PMU) dynamically tunes
the system to achieve the best trade-off between energy
consumption and performance, taking into account the
available energy in the battery and requirements (accu-
racy, latency, etc.) of the target application.
The current consumed by each of the previous component
is presented in Table I.
Component Average current (mA)
ECG chip 0.400
ICG chip 0.900
STM32L151 (active) 10.500
STM32L151 (standby) 0.020
Radio (TX) 11.000
Radio (standby) 0.002
Gyroscope + Accelerometer 3.800
TABLE I: Current consumption for each component
IV. SOFTWARE DESIGN METHODOLOGY
The proposed algorithm flowchart for ICG and ECG signal
acquisition is depicted in Fig. 3. As this figure shows, we first
set the frequency of the current that we inject in the human
body. After passing it across the human body and obtaining the
developed voltage, methods for noise cancellation are applied
and hemodynamic parameters along with the fluid level are
detected.
A. Noise cancellation
In this work, we have developed methods that can run
in real-time on the embedded platform. We have used the
following methods for noise reduction:
1) ECG filtering:
• Baseline wander removal through morphological filtering
[21]: This method applies several erosion and dilation
operations to the original ECG signal to estimate the
baseline wander. It first applies an erosion followed by
a dilation, which removes peaks in the signal. Then, the
resultant waveforms with pits are removed by a dilation
followed by an erosion. The final result is an estimate of
the baseline drift. The correction of the baseline is then
done by subtracting this estimate from the original signal.
• Zero-phase band-pass filter for high-frequency noise and
artifact removal: A 32nd-order FIR bandpass filter with
cut-off frequencies f1 = 0.05Hz and f2 = 40Hz is used
for these purposes.
2) ICG filtering: After looking at the frequency spectrum
of the signal, we noticed that amplitudes of the components at
frequencies f > 20Hz were not significant in comparison with
those obtained at lower frequencies. Therefore, to minimize
any kind of high-frequency noise interference, we use a zero-
phase low-pass Butterworth filter with cut-off frequency f =
20Hz.
B. ICG characteristic points
After applying an alternating electric current across the hu-
man body (Fig. 1), we first get the thoracic bioimpedance, Z0.
Analysis of bioimpedance signal assumes that the resistance to
electric current is inversely proportional to the distribution of
body water and electrolytes. Lean tissues are high conductors
of electric current due to their large amount of water and
electrolytes, and therefore, they show low resistance to the
passage of a current. On the other side, fat and bone have
low conductivity and, with a smaller quantity of fluids and
electrolytes, they show high electrical resistance [22]. ICG
signal is then calculated as:
ICG = −dZdt
A typical ICG waveform along with an ECG waveform is
depicted in Fig. 5. Points B, C and X are the three main
characteristic points of the ICG signal. Point B represents the
opening of the aortic valve, while point X denotes its closure
[23]. Changes in the ICG are generated by fluctuations in
blood volume and flow velocity in the ascending aorta during
each heart cycle. The time interval between point B and point
Fig. 5: ICG and ECG waveform (cf. [28])
X is the Left Ventriclar Ejection Time (LVET) while the time
interval between R-wave at the ECG and B point at the ICG is
the Pre-Ejection Period (PEP) [24]. LVET gives information
about how long it takes for the heart to pump blood out of the
left ventricle. PEP represents the electrical-mechanical delay
that occurs from the onset of depolarization to the beginning of
the ventricular contraction, that is when the aortic valve opens.
These parameters are called systolic time intervals and they are
used to estimate cardiac output (CO) and stroke volume (SV)
[25], [26]. For calculating LVET and PEP, the frequency of
the injected current was set to f = 50Khz, considering the
work done in [27].
C. Algorithm used for ICG characteristic point detection
The algorithm operates on a beat-to-beat basis and is
based on [28]. As our device is acquiring ECG and ICG
simultaneously, R peaks are detected by using Pan-Tompkins
algorithm [29]. After that, ICG signal included between two
consecutive ECG R-peaks was fed into the algorithm.
• C point – corresponds to the maximum value of the ICG
signal.
• B point – First the initial point B0 is estimated. B0 is
obtained based on the intersection of the line fit of the
ICG points between 40 % and 80 % of the amplitude
of point C with the horizontal axis. If the (+,−,+,−)
sign pattern of the second order derivative of ICG to the
left of the C-Point is detected, the B-point is defined
by the first minimum of the 3rd derivative to the left
of B0. If no sign pattern in the second derivative of
ICG is detected, the B-point is assumed to be the first
zero-crossing of the first derivative of the ICG to the left
of B0. Point Bnew in Fig. 5 represents the opening of
the aortic valve used in our algorithm, whereas the point
B represents its traditional definition mostly used in the
literature.
• X point – As an initial estimate of X point, the lowest
ICG negative minimum to the right of C point is
searched (X0). Point X is detected as the local minimum
of the 3rd derivative of the ICG to the left of (X0). It
should be mentioned that in [28], authors proposed a
slightly different approach for finding the initial estimate
for X point. Namely, in their study the closing of the
aortic valve is usually observed near the end of the
T-wave. Therefore, they are taking the lowest ICG
negative minimum in the interval RT ≤ t ≤ 1.75RT as
(X0), where RT represents the duration of the R-T ECG
segment. In their algorithm, the closure of the aortic
valve is represented as point Xnew, Fig. 5. The main
reason we have adjusted the algorithm is the well-known
fact that the end of a T wave is not a reliable marker
and it is not very clear where this wave ends. Point X
in Fig. 5 represents the closure of the aortic valve most
often reported in the literature.
V. EXPERIMENTS AND RESULTS
Five male subjects took part in this experiment. First, we
have recorded the ICG signal from our subjects using the tra-
ditional method for signal acquisition by placing the electrodes
on the chest and thorax, Fig. 1. Depending on the frequency
of the applied current, the path of the current may change
[30]. At low frequency (f < 50Khz), the current does not
penetrate the cell membrane, and the current passes through
the extracellular fluid. At a very high frequency (f ≥ 50Khz),
the current passes just through both, extracellular and intracel-
lular fluid. Due to this, signals were recorded for four different
frequencies: f ∈ {2, 10, 50, 100}Khz. Sampling frequency of
ECG and ICG signals was set to 250Hz, fs = 250Hz.
In our experiment, we investigate three different positions
of subjects’ arms during our measurements. Our goal is to
identify the position that has the best correlation with the
traditional measuring setup shown in Fig. 1. Moreover, we
want to quantify the worst measurement error that might occur
when the user’s arm is displaced from the intended position
during the measurement process. The subjects were required to
be standing in each of the positions. In Position 1, they were
asked to hold the device up to their chest. Then, they were
asked to stretch out their arms in front of them parallel to
the floor (Position 2). Finally, subjects were asked to slowly
put their arms down by their sides (Position 3). We chose
these positions to find the worst-case error that can occur if
users move the device during the measurement. Signals were
recorded for 30 seconds in each of the positions for each of
the four frequencies of the injected current.
Then, we analyzed the average thoracic bioimpedance (Zo).
The bioimpedance signal obtained through the traditional
electrode setup (Fig. 1) is shown in Fig. 6, whereas figures 7a,
7b, 7c represent the mean value of the bioimpedance signal
obtained from our device. From these figures, we can notice
the same behavior of the signals obtained from our device and
those obtained through the traditional electrode setup (Fig. 1).
Namely, the bioimpedance signal increases until f = 10Khz,
and then it starts decreasing. The correlation between the
signals obtained through the traditional setup (Fig. 1) and
those obtained from our device is tabulated in Tables II, III,
IV. According to our results, the lowest overall correlation is
obtained in Position 3.
Fig. 6: Thoracic Bioimpedance
(a) Positions 1 & 2
(b) Positions 1 & 3
(c) Positions 2 & 3
Fig. 7: Bioimpedance signals obtained from the device
We introduce the relative error as a criteria for defining the
worst-case error due to movements of the device during the
experiment, equations 1, 2, 3.
e21 =
Zposition2 − Zposition1
Zposition2
(1)
Subjects Correlation Coefficient
Subject 1 0.9081
Subject 2 0.9471
Subject 3 0.9827
Subject 4 0.8451
Subject 5 0.9251
TABLE II: Correlation Position 1 VS Thoracic bioimpedance
Subjects Correlation Coefficient
Subject 1 0.9747
Subject 2 0.9497
Subject 3 0.9938
Subject 4 0.9033
Subject 5 0.8461
TABLE III: Correlation Position 2 VS Thoracic bioimpedance
Subjects Correlation Coefficient
Subject 1 0.9737
Subject 2 0.9377
Subject 3 0.9908
Subject 4 0.8531
Subject 5 0.6919
TABLE IV: Correlation Position 3 VS Thoracic bioimpedance
e23 =
Zposition2 − Zposition3
Zposition2
(2)
e31 =
Zposition3 − Zposition1
Zposition3
(3)
Zpositionx represents the mean value of the bioimpedance
signal in position x, where x ∈ {1, 2, 3}. The obtained results
are depicted in Fig. 8. As it can be seen from Fig. 8c, the
lowest overall error occurs between position 3 and position 1,
while the highest overall error occurs between position 1 and
position 2, as shown in Fig. 8a.
For calculating parameters such as LVET and PEP we use
two different positions (Position 1 and 2). These positions
are selected due to the highest obtained error (i.e., worst
case scenarios). Characteristic ICG parameters along with the
heart rate (HR) of each subject are depicted in Fig. 9. HR is
calculated from the ECG signal obtained from our device.
We have done an evaluation of the computational complex-
ity of our algorithms, and we have concluded that we need just
between 40% and 50% of the duty cycle of the CPU power in
the STM32 micro-controller. As we are processing our signals
and extracting relevant parameters from them, we use just
0.1% of the duty cycle of the Radio for sending results such
as Z0, LV ET, PEP,HR. Therefore, considering the results
from the Table I, for our 710mAh battery, we get 106 hours
of operation on a single battery charge.
VI. CONCLUSIONS AND FUTURE WORK
In this paper, we have presented a touch-based ultra-low
power portable device which allows real-time beat-to-beat
ICG and ECG signals acquisition by touch. For our 710mAh
battery, assuming a continuous monitoring (the worst case
with 50% of duty cycle of STM32L151 and 1% of duty
cycle of Radio), we can reach 106 hours, thus allowing for
4 days of operation on a single battery charge. We have
(a) e21
(b) e23
(c) e31
Fig. 8: Relative error of bioimpedance value between different
positions
demonstrated that there is a strong correlation (r = 85 %)
between signals coming from our device and those obtained
using the traditional electrode configuration setup. In the
worst-case situation, the obtained error is always below 20%.
Therefore, slight displacement due to hands shaking does
not impact much the obtained results. Acquiring ECG and
ICG signal simultaneously from a portable device gives a
possibility of estimating hemodynamic parameters, as present
in the paper. These parameters can be transmitted wirelessly
to a physician for further review in order to prevent possi-
ble attacks. Obtaining biomedical signals by means of the
hand-held ultra-low power devices offers portability and the
option of managing complex patients in outpatient settings.
At the same time, these devices greatly simplify the work of
(a) Position 1
(b) Position 2
Fig. 9: Characteristic ICG parameters along with the HR of
each subject for the worst-case positions
hospital physicians in healthcare, as they can be easily used
autonomously by patients. As for the future work, we are
planning to expand our study on a larger number of subjects
and compare our results to those obtained from some already
existant ICG system.
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